SAN DIEGO--(BUSINESS WIRE)--Synteract, Inc., a full-service, global contract research organization (CRO) dedicated to meeting the clinical research needs of biotechnology, medical device, and pharmaceutical companies, has achieved Rave Accredited status in the Medidata Solutions (NASDAQ: MDSO) ASPire to Win® channel partner program. With this accreditation, Synteract has increased its Medidata Rave® expertise to be able to offer in-house database development and other services to provide superior customer service as well as faster timelines and reduced costs for clients.
